In recognition of Pancreatic Cancer Awareness Month, this November iconic buildings over Australia will light up purple to raise awareness for the disease and to celebrate and honour survivors and loved ones. Pancreatic cancer is the third leading cause of cancer...

A new clinical trial for people with advanced pancreatic cancer, has now commenced in Australia. The trial led by Amplia Therapeutics, in collaboration with Professor Paul Timpson from the Invasion and Metastasis Lab at The Garvan Institute of Medical Research, will...

Pancreatic cancer is one of the most aggressive cancers and five-year survival rates are just 10%. A very small number of patients live longer, with less than 2% surviving more than 10 years after diagnosis. Researchers have been working to understand how this cancer...